AsOf

Recorded or changed on this day 2026-11-08

2,001–2,050 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 5,577,000,000 United States dollar
Amgen operating income: 5,577,000,000 United States dollar, claim clm_18B2DC42BBCB · ended · superseded by clm_D1F7CCF21F2B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 43,534,000,000 United States dollar
Amgen total assets: 43,534,000,000 United States dollar, claim clm_19765841AC5F · ended · superseded by clm_CA6A5441CDCF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 585,693,775 shares
Amgen shares outstanding: 585,693,775 shares, claim clm_1A0716269BBF · ended · superseded by clm_0909C448022C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,841,000,000 United States dollar
Amgen quarterly net income: 2,841,000,000 United States dollar, claim clm_1A5FC1FEF0D4 · ended · superseded by clm_2B91AA0524E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 23,553,000,000 United States dollar
Amgen total equity: 23,553,000,000 United States dollar, claim clm_1B908EDA7C06 · ended · superseded by clm_DF80452A7941 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,364,000,000 United States dollar
Amgen quarterly operating income: 1,364,000,000 United States dollar, claim clm_1C381C3663B1 · ended · superseded by clm_941927EE0CBF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,863,000,000 United States dollar
Amgen quarterly net income: 1,863,000,000 United States dollar, claim clm_1CD07968584F · ended · superseded by clm_363FD391E3A4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,269,000,000 United States dollar
Amgen quarterly net income: 1,269,000,000 United States dollar, claim clm_1D9A473B7296 · ended · superseded by clm_B8CC66F883EA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,870,000,000 United States dollar
Amgen quarterly net income: 1,870,000,000 United States dollar, claim clm_1DC1E9754547 · ended · superseded by clm_D60223B7773B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 67,004,000,000 United States dollar
Amgen total assets: 67,004,000,000 United States dollar, claim clm_1DC4233C61D6 · ended · superseded by clm_CF482D232326 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,550,000,000 United States dollar
Amgen quarterly operating income: 1,550,000,000 United States dollar, claim clm_1DF1A1C609E1 · ended · superseded by clm_B0A9F616BD13 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 61,669,000,000 United States dollar
Amgen total assets: 61,669,000,000 United States dollar, claim clm_1DF598E8A627 · ended · superseded by clm_62DDE4D8FE1C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 10,263,000,000 United States dollar
Amgen operating income: 10,263,000,000 United States dollar, claim clm_1E3D48FD1C81 · ended · superseded by clm_10BA888AB580 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,816,000,000 United States dollar
Amgen quarterly revenue: 3,816,000,000 United States dollar, claim clm_1E3DCB2075FA · ended · superseded by clm_5C7EB0130754 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,179,000,000 United States dollar
Amgen quarterly net income: 2,179,000,000 United States dollar, claim clm_206CA4F50FEA · ended · superseded by clm_2207406F389E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 15,053,000,000 United States dollar
Amgen revenue: 15,053,000,000 United States dollar, claim clm_21002187AEE3 · ended · superseded by clm_C7A9E438A984 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 63,700,000,000 United States dollar
Amgen total assets: 63,700,000,000 United States dollar, claim clm_2130B296B9EF · ended · superseded by clm_3E5FFAF79DFE · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · headquarters · Thousand Oaks
Amgen headquarters: Thousand Oaks, claim clm_213F34219223 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,968,000,000 United States dollar
Amgen quarterly net income: 1,968,000,000 United States dollar, claim clm_2207406F389E · ended · superseded by clm_414F61974288 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,296,000,000 United States dollar
Amgen quarterly net income: 2,296,000,000 United States dollar, claim clm_2220944AC708 · ended · superseded by clm_17338F01F53F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 11,956,000,000 United States dollar
Amgen cash and equivalents: 11,956,000,000 United States dollar, claim clm_226AFDC7ECB0 · ended · superseded by clm_24506D67CAC5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 609,935,682 shares
Amgen shares outstanding: 609,935,682 shares, claim clm_226B9B63D1EC · ended · superseded by clm_FC64A72BD0A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 5,545,000,000 United States dollar
Amgen operating income: 5,545,000,000 United States dollar, claim clm_2282EE661302 · ended · superseded by clm_E05A3DDD94DD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 539,067,675 shares
Amgen shares outstanding: 539,067,675 shares, claim clm_231B73F793B2 · ended · superseded by clm_04AAD52EA082 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,777,000,000 United States dollar
Amgen cash and equivalents: 2,777,000,000 United States dollar, claim clm_23946C33E856 · ended · superseded by clm_06EAF5224086 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,945,000,000 United States dollar
Amgen cash and equivalents: 6,945,000,000 United States dollar, claim clm_24506D67CAC5 · ended · superseded by clm_D20943685A4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,619,000,000 United States dollar
Amgen total equity: 9,619,000,000 United States dollar, claim clm_25EEFB9574DF · ended · superseded by clm_DEE8552AC913 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,048,000,000 United States dollar
Amgen quarterly revenue: 4,048,000,000 United States dollar, claim clm_2763B8997D8B · ended · superseded by clm_D4DC1453EF41 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,370,000,000 United States dollar
Amgen quarterly revenue: 5,370,000,000 United States dollar, claim clm_28F3330C360C · ended · superseded by clm_85E7DB9BD8C5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 97,154,000,000 United States dollar
Amgen total assets: 97,154,000,000 United States dollar, claim clm_28FA2561E047 · ended · superseded by clm_50E0EA85B3CF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,688,000,000 United States dollar
Amgen quarterly revenue: 5,688,000,000 United States dollar, claim clm_293E3106D6E2 · ended · superseded by clm_E9FEE791CE06 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,944,000,000 United States dollar
Amgen quarterly revenue: 3,944,000,000 United States dollar, claim clm_296C33E5B63E · ended · superseded by clm_2763B8997D8B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,151,000,000 United States dollar
Amgen quarterly net income: 2,151,000,000 United States dollar, claim clm_2970793B064E · ended · superseded by clm_B82AB1C3159B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 3,653,000,000 United States dollar
Amgen total equity: 3,653,000,000 United States dollar, claim clm_2983532AC508 · ended · superseded by clm_4BA44A742FE5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,527,000,000 United States dollar
Amgen quarterly operating income: 2,527,000,000 United States dollar, claim clm_29CEBD7716C0 · ended · superseded by clm_F7F0878C88D4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,073,000,000 United States dollar
Amgen quarterly net income: 1,073,000,000 United States dollar, claim clm_2AFFA5A382C9 · ended · superseded by clm_82CA77D552C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 25,424,000,000 United States dollar
Amgen revenue: 25,424,000,000 United States dollar, claim clm_2B6D201D77C0 · ended · superseded by clm_77883252E88F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,379,000,000 United States dollar
Amgen quarterly net income: 1,379,000,000 United States dollar, claim clm_2B91AA0524E8 · ended · superseded by clm_12D32BFD074A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,203,000,000 United States dollar
Amgen cash and equivalents: 5,203,000,000 United States dollar, claim clm_2C58ADDE4DED · ended · superseded by clm_BDE07F9B7128 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 1,979,000,000 United States dollar
Amgen net income: 1,979,000,000 United States dollar, claim clm_2C7BDDED6E27 · ended · superseded by clm_7F963F7A3BF5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 932,452,902 shares
Amgen shares outstanding: 932,452,902 shares, claim clm_2D844BCDB1A9 · ended · superseded by clm_E1D7B78E1C33 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,832,000,000 United States dollar
Amgen quarterly operating income: 2,832,000,000 United States dollar, claim clm_2D8C36C0626B · ended · superseded by clm_3A298D9EC5BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,741,000,000 United States dollar
Amgen cash and equivalents: 9,741,000,000 United States dollar, claim clm_2D8F2FC9E463 · ended · superseded by clm_0DBEED486A33 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,806,000,000 United States dollar
Amgen cash and equivalents: 5,806,000,000 United States dollar, claim clm_2E4B5E4DFAE5 · ended · superseded by clm_54048E292013 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 538,480,671 shares
Amgen shares outstanding: 538,480,671 shares, claim clm_2EA05ED8BE57 · ended · superseded by clm_231B73F793B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 22,741,000,000 United States dollar
Amgen total equity: 22,741,000,000 United States dollar, claim clm_2F8840B9A878 · ended · superseded by clm_905DE244F62B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,884,000,000 United States dollar
Amgen cash and equivalents: 2,884,000,000 United States dollar, claim clm_3007B813C9B4 · ended · superseded by clm_66B8EB012276 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,748,000,000 United States dollar
Amgen quarterly revenue: 4,748,000,000 United States dollar, claim clm_3033018610D0 · ended · superseded by clm_4A26C5460842 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 5,214,000,000 United States dollar
Amgen operating income: 5,214,000,000 United States dollar, claim clm_3327385ED8BC · ended · superseded by clm_46A559E6C041 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 22,991,000,000 United States dollar
Amgen revenue: 22,991,000,000 United States dollar, claim clm_33F31087C483 · ended · superseded by clm_D4EEBB71EC7D · 1 source (1 primary) · conf 0.95

What the statuses mean